LICENSE AGREEMENTLicense Agreement • March 12th, 2008 • Biomimetic Therapeutics, Inc. • Surgical & medical instruments & apparatus • Delaware
This Exclusive License Agreement (this “Agreement”) is entered into on January 4, 2008 (the “Effective Date”) between BioMimetic Therapeutics, Inc. (“BMTI”), a Delaware corporation, and Luitpold Pharmaceuticals, Inc. (“Luitpold”), a New York corporation (each, individually, a “Party” and, collectively, the “Parties”).
AGREEMENT TERMINATING MANUFACTURING AND SUPPLY AGREEMENTAgreement Terminating • March 12th, 2008 • Biomimetic Therapeutics, Inc. • Surgical & medical instruments & apparatus • Delaware
THIS AGREEMENT TERMINATING MANUFACTURING AND SUPPLY AGREEMENT (this “Agreement”), is entered into as of January 4, 2008, between BioMimetic Therapeutics, Inc., a Delaware corporation (f/k/a BioMimetic Pharmaceuticals, Inc.) (“BMTI”), and Luitpold Pharmaceuticals, Inc., a New York corporation (“Luitpold”). BMTI and Luitpold are each a “party” and are together, the “parties” to this Agreement.
EMPLOYMENT AGREEMENTEmployment Agreement • March 12th, 2008 • Biomimetic Therapeutics, Inc. • Surgical & medical instruments & apparatus • Tennessee
This EMPLOYMENT AGREEMENT (“Agreement”) made effective as of January 1, 2008 by and between BioMimetic Therapeutics, Inc., a Delaware corporation (the “Company”), and Dr. Samuel E. Lynch (the “Executive”).
AGREEMENT TERMINATING RESEARCH, DEVELOPMENT AND MARKETING AGREEMENTAgreement Terminating Research, Development • March 12th, 2008 • Biomimetic Therapeutics, Inc. • Surgical & medical instruments & apparatus • Delaware
This AGREEMENT TERMINATING RESEARCH, DEVELOPMENT AND MARKETING AGREEMENT (this “Agreement”), is entered into as of January 4, 2008, between BioMimetic Therapeutics, Inc., a Delaware corporation (f/k/a BioMimetic Pharmaceuticals, Inc.) (“BMTI”), and Luitpold Pharmaceuticals, Inc., a New York corporation (“Luitpold”).
AMENDMENT AND WAIVER AGREEMENT with respect to ASSET PURCHASE AGREEMENTAnd Waiver Agreement • March 12th, 2008 • Biomimetic Therapeutics, Inc. • Surgical & medical instruments & apparatus
THIS AMENDMENT AND WAIVER AGREEMENT WITH RESPECT TO ASSET PURCHASE AGREEMENT (this “Amendment”) is entered into and effective as of January 4, 2008, between BioMimetic Therapeutics, Inc., a Delaware corporation (“Seller”), and Luitpold Pharmaceuticals, Inc., a New York corporation (“Buyer”).
AMENDED AND RESTATED EXCLUSIVE SUBLICENSE AGREEMENTAmended and Restated Exclusive Sublicense Agreement • March 12th, 2008 • Biomimetic Therapeutics, Inc. • Surgical & medical instruments & apparatus • Delaware
This Amended and Restated Exclusive Sublicense Agreement (“Agreement”) is entered into on January 4, 2008 (“Effective Date”) between BioMimetic Therapeutics, Inc. (“BMTI”), a Delaware corporation (formerly known as BioMimetic Pharmaceuticals, Inc.) and Luitpold Pharmaceuticals, Inc. (“Luitpold”), a New York corporation (each, individually, a “Party” and, collectively, the “Parties”).
ASSET PURCHASE AGREEMENT between BIOMIMETIC THERAPEUTICS, INC. and LUITPOLD PHARMACEUTICALS, INC. Dated as of December 14, 2007Asset Purchase Agreement • March 12th, 2008 • Biomimetic Therapeutics, Inc. • Surgical & medical instruments & apparatus • Delaware
ASSET PURCHASE AGREEMENT, dated as of December 14, 2007, between BioMimetic Therapeutics, Inc., a Delaware corporation (“Seller”), and Luitpold Pharmaceuticals, Inc., a New York corporation (“Buyer”).
SUPPLY AGREEMENTSupply Agreement • March 12th, 2008 • Biomimetic Therapeutics, Inc. • Surgical & medical instruments & apparatus • Delaware
This Supply Agreement (this “Agreement”), effective as of January 4, 2008 (the “Effective Date”), is made by and between BioMimetic Therapeutics, Inc., a Delaware corporation with offices at 389-A Nichol Mill Lane, Franklin, TN 37067 (“BMTI”), and Luitpold Pharmaceuticals, Inc., a New York corporation with offices at One Luitpold Drive, P.O. Box 9001, Shirley, NY 11967 (“Luitpold”).
